MRKR Marker Therapeutics 8-K2021Regulation FD Disclosure
13 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
MRKR 8-K Filings
- 13 Jan 21 Regulation FD Disclosure
- 5 Jan 21 Marker Therapeutics Announces FDA Lifted Partial Clinical Hold on Phase 2 AML Clinical Trial
- 9 Nov 20 Marker Therapeutics Reports Third Quarter 2020 Operating and Financial Results
- 10 Aug 20 Marker Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…